SANTA FE, N.M., March 30 /PRNewswire-FirstCall/ -- CytoDyn, Inc. has appointed Gregory A. Gould, CPA to its Board of Directors to fill a vacancy. Mr. Gould will serve as an independent financial expert on the Board’s Audit Committee.
Mr. Gould has worked in the life sciences industry for the past decade as a senior executive. Until its acquisition by QLT, Inc. for approximately $850 million in November of 2004, Mr. Gould served as Chief Financial Officer, Treasurer and Secretary of Atrix Laboratories, Inc. Atrix was a Nasdaq company with over $60 million in annualized revenues and 160 employees in two countries.
From February of 1996 until its acquisition by KRG Capital Partners in October of 2003, Mr. Gould was the Director of Finance, and then Chief Financial Officer and Treasurer of Colorado MEDtech, a Nasdaq company with over $77 million in annualized revenues and 500 employees located in four States.
Mr. Gould received his B.S. in Business Administration form the University of Colorado at Boulder in 1989. He is a Certified Public Accountant in Colorado and a member of the Colorado Society of Certified Public Accountants.
Allen D. Allen, CytoDyn CEO stated, “We are very pleased to have such a well-qualified financial expert serving on our Board of Directors and Audit Committee. I know that as the newest member of our team, Greg will make significant contributions to our Company.”
CytoDyn
Corinne Allen (505) 988-5520
CytoDyn, Inc.
CONTACT: Corinne Allen, +1-505-988-5520, for CytoDyn, Inc.
